Reality… You Can Run from It, Face It, or Embrace It
At REALITYRx communication, we choose to embrace the realities of pharmaceutical marketing in today’s changing healthcare environment.
Delivering the Right Dose for Your Brand
For more than fifteen years, REALITYRx has embraced the realities of the ever-changing healthcare industry. We thrive in an environment shaped by healthcare providers’ needs, patient and consumer demands, regulatory requirements, technological advances, and budget constraints. We believe that healthcare agencies need to be scalable and adaptable to a dynamic, modern marketplace.
We are a savvy, experienced, global healthcare agency offering a full range of marketing and advertising services across the pharmaceutical, biotech, diagnostic, and medical device industries. Our unique strategies and high-impact creative are proven to grow brands and drive market share. We provide personalized integrated solutions that span the entire healthcare continuum, reaching physicians, nurses, healthcare systems, administrators, insurers, patients, and caregivers.
REAL WORLD SUCCESS
REAL WORLD SUCCESS
A FULL-SERVICE GLOBAL HEALTHCARE AGENCY
Offering the right dose of strategy, creative, and execution, connecting with target audiences, and delivering measurable ROI.
REALITYRx recognized for excellence in corporate communications
At the recent 2024 MANNY AWARDS, celebrating excellence in healthcare communications, REALITYRx was named a finalist in the “Best Corporate Campaign” category. The campaign was developed for one of REALITYRx’s clients, Bracco Diagnostics, Inc, a global leader in...
Blood vs stool. A new colon cancer screening option may increase adherence.
Blood vs stool. A new colon cancer screening option may increase adherence.1,2 With colorectal cancer (also known as colon cancer) on the rise, the disease may soon be detected through a simple blood test.3 Colorectal cancer (CRC) is cancer of the colon and/or...
Predicting CIP in Advanced NSCLC Patients Using CT Quantification of Preexisting Lung GGO
The following is a summary of “Quantification of preexisting lung ground glass opacities on CT for predicting checkpoint inhibitor pneumonitis in advanced non-small cell lung cancer patients,” published in the February 2024 issue of Oncology by Wang et al. Immune...